E6005
E6005-J081-101
Phase 2 small_molecule completed
Quick answer
E6005 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Organon Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Organon Pharma Pty Ltd
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed